49 results on '"Walsh, E. E."'
Search Results
2. Challenges and Opportunities in Developing Respiratory Syncytial Virus Therapeutics
3. Reply to Musher et al
4. Clinical Impact of Human Coronaviruses 229E and OC43 Infection in Diverse Adult Populations
5. Bacterial Complications of Respiratory Tract Viral Illness: A Comprehensive Evaluation
6. Statins and Influenza: Can We Move Forward?
7. Viral Pneumonia in Older Adults
8. Decisional Attributes of Patients With Diabetes: The aspirin choice
9. Monoclonal antibody neutralization escape mutants of respiratory syncytial virus with unique alterations in the attachment (G) protein.
10. Respiratory syncytial virus infection in the elderly
11. Humoral, Mucosal, and Cellular Immune Response to Topical Immunization with a Subunit Respiratory Syncytial Virus Vaccine
12. Comparison of Antibody Concentrations and Protective Activity of Respiratory Syncytial Virus Immune Globulin and Conventional Immune Globulin
13. Immunogenicity of Purified F Glycoprotein of Respiratory Syncytial Virus: Clinical and Immune Responses to Subsequent Natural Infection in Children
14. Transmission of Chlamydia pneumoniae
15. Protective Activity of a Human Respiratory Syncytial Virus Immune Globulin Prepared from Donors Screened by Microneutralization Assay
16. Group-Specific Serum Antibody Responses in Children with Primary and Recurrent Respiratory Syncytial Virus Infections
17. Immunity to and Frequency of Reinfection with Respiratory Syncytial Virus
18. Interleukin-1-Inhibitor Activity Induced by Respiratory Syncytial Virus: Abrogation of Virus-Specific and Alternate Human Lymphocyte Proliferative Responses
19. Occurrence of Groups A and B of Respiratory Syncytial Virus over 15 Years: Associated Epidemiologic and Clinical Characteristics in Hospitalized and Ambulatory Children
20. Serologic Evidence of Respiratory Syncytial Virus Infection in Nursing Home Patients
21. Immunogenicity of a Purified Fragment of 170 Yellow Fever Envelope Protein
22. Cell surface expression of yellow fever virus non-structural glycoprotein NS1: consequences of interaction with antibody
23. Immunization with Glycoprotein Subunits of Respiratory Syncytial Virus to Protect Cotton Rats Against Viral Infection
24. Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity
25. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48.
26. Studies of Passive Immunotherapy for Infections of Respiratory Syncytial Virus in the Respiratory Tract of a Primate Model
27. Strain-Specific Serum Antibody Responses in Infants Undergoing Primary Infection with Respiratory Syncytial Virus
28. Analysis of 17D Yellow Fever Virus Envelope Protein Epitopes Using Monoclonal Antibodies
29. Comparison of Antigenic Sites of Subtype-specific Respiratory Syncytial Virus Attachment Proteins
30. Immunological Differences between the Envelope Glycoproteins of Two Strains of Human Respiratory Syncytial Virus
31. Protection of Mice Against Dengue 2 Virus Encephalitis by Immunization with the Dengue 2 Virus Non-structural Glycoprotein NS1
32. Lethal 17D Yellow Fever Encephalitis in Mice. I. Passive Protection by Monoclonal Antibodies to the Envelope Proteins of 17D Yellow Fever and Dengue 2 Viruses
33. Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection
34. Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus
35. Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein
36. Purification and Characterization of the Respiratory Syncytial Virus Fusion Protein
37. Respiratory Syncytial Virus Infection of Human Mononuclear Leukocytes in Vitro and in Vivo
38. Macrophages are required for influenza virus infection of human lymphocytes.
39. Differential immunoglobulin G subclass antibody titers to respiratory syncytial virus F and G glycoproteins in adults
40. Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection
41. Purification and Characterization of GP90, One of the Envelope Glycoproteins of Respiratory Syncytial Virus
42. Serum immunoglobulin G antibody subclass response to respiratory syncytial virus F and G glycoproteins after first, second, and third infections
43. Identification of the Virus-Specific Proteins of Respiratory Syncytial Virus Temperature-Sensitive Mutants by Immunoprecipitation
44. Analysis of the Respiratory Syncytial Virus Fusion Protein Using Monoclonal and Polyclonal Antibodies
45. Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection
46. Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine
47. Rapid detection of respiratory syncytial virus with a monoclonal antibody
48. Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies
49. Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.